Skip to main content

Man Group plc

SEC CIK
0001637460
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
436,956
Value
$272.5M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of REGN by Man Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026436,956$272.5M0.5%+121,744+38.6%AddedHolders
Q1 2026315,212$243.5M0.5%+97,100+44.5%AddedHolders
Q4 2025218,112$168.4M0.3%−53,595−19.7%ReducedHolders
Q3 2025271,707$152.8M0.3%+195,724+257.6%AddedHolders
Q2 202575,983$39.9M0.1%+40,397+113.5%AddedHolders
Q1 202535,586$22.6M0.1%−558−1.5%ReducedHolders
Q4 202436,144$25.7M0.1%−24,377−40.3%ReducedHolders
Q3 202460,521$63.6M0.2%+8,777+17.0%AddedHolders
Q2 202451,744$54.4M0.1%−56,728−52.3%ReducedHolders
Q1 2024108,472$104.4M0.3%+14,912+15.9%AddedHolders
Q4 202393,560$82.2M0.2%––Holders
Q3 2023–$33.2M0.1%––Holders
Q2 2023116,636$83.8M0.3%––Holders
Q1 2023–$24.7M0.1%––Holders
Q4 202277,120$55.6M0.2%+57,473+292.5%AddedHolders
Q3 202219,647$13.5M0.1%––Holders
Q2 2022–$22.8M0.1%––Holders
Q1 202229,970$20.9M0.1%−117,219−79.6%ReducedHolders
Q4 2021147,189$93.0M0.3%+66,819+83.1%AddedHolders
Q3 202180,370$48.6M0.2%−28,583−26.2%ReducedHolders
Q2 2021108,953$60.9M0.2%−11,314−9.4%ReducedHolders
Q1 2021120,267$56.9M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.